浙江康恩贝制药股份有限公司关于2022年股票期权激励计划首次授予股票期权第一个行权期限制行权期间的提示性公告

Group 1 - The company has announced a restriction on the exercise period for stock options under its 2022 stock option incentive plan, which is set from August 13, 2025, to August 28, 2025, during which all incentive recipients will be restricted from exercising their options [1][2] - The stock option incentive plan has entered the exercise period, and the company will apply to the China Securities Depository and Clearing Corporation Limited Shanghai Branch for the relevant matters regarding the restriction on exercise [1]